Psychotherapy: what's metaphysical got to do with it?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Works matching IS 15505952 AND DT 2009 AND VI 6 AND IP 12
Results: 36
1
2
PsychRx. FDA approves Lilly's Zyprexa for two adolescent indications.
- Published in:
- 2009
- Publication type:
- Journal Article
3
Can behavioral sensory processing problems guide us to a better pharmacological management of children with attention deficit hyperactivity disorder? A case report.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
4
Editor's message.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
5
PsychRx. US FDA approves Seroquel XR for add-on treatment of major depressive disorder.
- Published in:
- 2009
- Publication type:
- Journal Article
6
PsychRx. Phase III study demonstrates Invega Sustenna (paliperidone palmitate) statistically similar to Risperdal Consta (risperidone) long-acting injection.
- Published in:
- 2009
- Publication type:
- Journal Article
7
Author response.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
8
Cognitive behavior therapy for people with schizophrenia.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
9
PsychRx. FDA approves generic Aricept to treat dementia related to Alzheimer's disease.
- Published in:
- 2009
- Publication type:
- Journal Article
10
Benzodiazepines risk, abuse, and dependence: a tsunami in a tea cup.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
11
Cannabis-induced bipolar disorder with psychotic features: a case report.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
12
PsychRx. Antiepileptic drugs not associated with increased risk of suicide attempts in patients with bipolar disorder.
- Published in:
- 2009
- Publication type:
- Journal Article
13
Over-the-counter bulking supplements and panic attacks.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
14
The use of placebo-controlled clinical trials for the approval of psychiatric drugs: part II---Ethical considerations related to the individual participant.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
15
PsychRx. FDA approves Lilly's Zyprexa Relprevv for treatment of schizophrenia in adults.
- Published in:
- 2009
- Publication type:
- Journal Article
16
Sleep disorders in substance abusers.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
17
PsychRx. Drug for Alzheimer disease does not appear to slow cognitive decline.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
18
Borderline personality disorder in the medical setting: unmasking and managing the difficult patient.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
19
BORDERLINE PERSONALITY DISORDER IN THE MEDICAL SETTING: Unmasking and Managing the Difficult Patient.
- Published in:
- 2009
- By:
- Publication type:
- Book Review
20
Cannabis-Induced Bipolar Disorder with Psychotic Features: A Case Report.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 44
- By:
- Publication type:
- Article
21
Can Behavioral Sensory Processing Problems Guide Us to a Better Pharmacological Management of Children with Attention Deficit Hyperactivity Disorder? A Case Report.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 40
- By:
- Publication type:
- Article
22
COGNITIVE BEHAVIOR THERAPY FOR PEOPLE WITH SCHIZOPHRENIA.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 32
- By:
- Publication type:
- Article
23
PSYCHOTHERAPY: What's Metaphysical Got to Do With It?
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 26
- By:
- Publication type:
- Article
24
THE USE OF PLACEBO-CONTROLLED CLINICAL TRIALS FOR THE APPROVAL OF PSYCHIATRIC DRUGS: Part II -- Ethical Considerations Related to the Individual Participant.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 19
- By:
- Publication type:
- Article
25
OVER-THE-COUNTER BULKING SUPPLEMENTS AND PANIC ATTACKS.
- Published in:
- 2009
- By:
- Publication type:
- Letter
26
SLEEP DISORDERS IN SUBSTANCE ABUSERS.
- Published in:
- 2009
- By:
- Publication type:
- Letter
27
AUTHOR RESPONSE.
- Published in:
- 2009
- By:
- Publication type:
- Letter
28
BENZODIAZEPINES RISK, ABUSE, AND DEPENDENCE: A TSUNAMI IN A TEA CUP.
- Published in:
- 2009
- By:
- Publication type:
- Letter
29
ANTIEPILEPTIC DRUGS NOT ASSOCIATED WITH INCREASED RISK OF SUICIDE ATTEMPTS IN PATIENTS WITH BIPOLAR DISORDER.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 11
- Publication type:
- Article
30
US FDA APPROVES SEROQUEL XR FOR ADD-ON TREATMENT OF MAJOR DEPRESSIVE DISORDER.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 11
- Publication type:
- Article
31
FDA APPROVES LILLY'S ZYPREXA FOR TWO ADOLESCENT INDICATIONS.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 10
- Publication type:
- Article
32
PHASE III STUDY DEMONSTRATES INVEGA SUSTENNA (PALIPERIDONE PALMITATE) STATISTICALLY SIMILAR TO RISPERDAL CONSTA (RISPERIDONE) LONG-ACTING INJECTION.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 10
- Publication type:
- Article
33
FDA APPROVES LILLY'S ZYPREXA RELPREVV FOR TREATMENT OF SCHIZOPHRENIA IN ADULTS.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 9
- Publication type:
- Article
34
FDA APPROVES GENERIC ARICEPT TO TREAT DEMENTIA RELATED TO ALZHEIMER'S DISEASE.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 9
- Publication type:
- Article
35
Editor's Message.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 3
- By:
- Publication type:
- Article
36
DRUG FOR ALZHEIMER DISEASE DOES NOT APPEAR TO SLOW COGNITIVE DECLINE.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 12, p. 9
- Publication type:
- Article